Published Online
on July 3, 2006

A more recent version of this article appeared on August 1, 2006

This Article Full Text (PDF) All Versions of this Article: 48/2/187    most recent 01.HYP.0000231939.40959.60v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, H. Articles by Staessen, J. A. Search for Related Content PubMed PubMed Citation Articles by Zhang, H. Articles by Staessen, J. A. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure Stroke Related Collections Cerebrovascular disease/stroke Risk Factors Clinical Studies Embolic stroke Other Stroke Treatment - Medical Epidemiology

Submitted on February 26, 2006
Revised on March 17, 2006

Blood Pressure Lowering for Primary and Secondary Prevention of Stroke

Haifeng Zhang; Lutgarde Thijs; and Jan A. Staessen^*

From the Studies Coordinating Centre (H.Z., L.T., J.A.S.), Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Belgium; and the Department of Cardiology (H.Z.), First Affiliated Hospital, Nanjing Medical University, Nanjing, China.

^* To whom correspondence should be addressed. E-mail: jan.staesssen{at}med.kuleuven.be.

This article has been cited by other articles:

				M R Law, J K Morris, and N J Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ, May 19, 2009; 338(may19_1): b1665 - b1665. [Abstract] [Full Text] [PDF]

				L. Castilla-Guerra, M. del Carmen Fernandez-Moreno, and M. D. Jimenez-Hernandez Blockage of the Renin-Angiotensin System in the Secondary Prevention of Stroke: Beneficial Effects Beyond Blood Pressure Reduction? Stroke, March 1, 2009; 40(3): e75 - e75. [Full Text] [PDF]

				P. Talelli and R. J. Greenwood Review: Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes? Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 387 - 405. [Abstract] [PDF]

				B. Williams The Year in Hypertension J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1803 - 1817. [Full Text] [PDF]

				C. S. Rigsby, A. E. Burch, S. Ogbi, D. M. Pollock, and A. M. Dorrance Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1754 - R1763. [Abstract] [Full Text] [PDF]

				J. A Staessen and E. O'Brien Will generic hypertension guidelines reduce the proliferation of directives? Heart, July 1, 2007; 93(7): 775 - 777. [Full Text] [PDF]

				J. Redon, L. Cea-Calvo, J. V. Lozano, J. C. Marti-Canales, J. L. Llisterri, J. Aznar, J. Gonzalez-Esteban, and on behalf of the investigators of the PREV-ICTUS S Differences in Blood Pressure Control and Stroke Mortality Across Spain: The Prevencion de Riesgo de Ictus (PREV-ICTUS) Study Hypertension, April 1, 2007; 49(4): 799 - 805. [Abstract] [Full Text] [PDF]

				F. H. Messerli and J. A. Staessen Amlodipine Better Than Lisinopril?: How One Randomized Clinical Trial Ended Fallacies From Observational Studies Hypertension, September 1, 2006; 48(3): 359 - 361. [Full Text] [PDF]